Zinzino Reports Strong Q1 2026 Results as Revenue, Profitability, Global Expansion Continue to Accelerate

GOTHENBURG, SWEDEN – Zinzino (publ) (ZZ-B.ST) has released its Interim Report for Q1 2026, reporting continued double-digit growth, improving profitability, and further international expansion as the company continues to strengthen its global position in the health and wellness sector.

According to the company’s latest financial report, first quarter revenue reached SEK 922.1 million, representing 27% year-over-year growth, or 37% growth in local currencies.

EBITDA increased to SEK 142.3 million, while the EBITDA margin improved significantly to 15.4%, up from 10.9% during the same period last year.

The company also reported net profit of SEK 104.5 million for the quarter – nearly doubling from SEK 56 million in Q1 2025 – alongside strong operating cash flow of SEK 125.6 million.

Zinzino stated that the improved profitability was driven by stronger gross margins, operational scale efficiencies, and continued momentum across global markets, even with ongoing integration following the acquisition of It Works! during the quarter.

In addition to the It Works integration, Zinzino officially launched Peru as its first market in South America during Q1, marking another milestone in the company’s international expansion strategy.

The results have also been positively received by Zinzino’s field leadership and distributor community, particularly around the company’s combination of revenue growth, expanding profitability, and continued international expansion. Insights shared on social media following the report focused on the company’s improving margins, recurring revenue model, global infrastructure development, and continued acquisition integration efforts.

The company’s Q1 report reflected continued strength across several key financial metrics:

• Revenue growth of 27% year-over-year
• Local currency growth of 37%
• Gross profit margin improvement to 37.0%
• EBITDA margin increase to 15.4%
• Net profit growth to SEK 104.5 million
• Operating cash flow increase to SEK 125.6 million

The full Q1 2026 Interim Report is also available through Zinzino’s investor relations website.

About Zinzino

Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.

Zinzino’s scientifically proven nutritional supplements are available in more than 100 markets across the world. Zinzino has acquired all assets in the health and wellness companies It Works!,  Enhanzz Global, Truvy, Bodē Pro, Valentus, Zurvita and Xelliss, and Sanki Global. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters are in Gothenburg, Sweden, with additional offices in Europe, Asia, and Australia. For more information, please visit www.zinzino.com